Exchange Announcement • 01 Dec 2025 22:05
Exchange Announcement • 19 Nov 2025 05:23
Exchange Announcement • 19 Nov 2025 05:20
Exchange Announcement • 10 Nov 2025 22:05
Exchange Announcement • 10 Nov 2025 19:21
Search or
𝛼SK
𝛼SKENTITY
Cadrenal Therapeutics (CVKD US)
Cadrenal Therapeutics (CVKD US)
7
Analysis
Health Care • United States
Cadrenal Therapeutics, Inc. operates as a biotech company. The Company focuses on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease, or ESRD, and atrial fibrillation. Cadrenal Therapeutics serves customers worldwide.
morex